Sort
8,912 grants matching “sars cov 2”
Regulation Of Lung Immunity By Antibody Glycosylation
$860,851Taia Wang · Stanford University · R01 · FY2025 · AI
Longitudinal Analyses of Antibody Responses to SARS-CoV-2
$860,171James E Robinson · Tulane University Of Louisiana · U54 · FY2020 · CA
Technology Core
$859,747William Owen Osburn · Johns Hopkins University · U54 · FY2025 · EB
Systems Immunogenetics of Emerging Coronavirus Infections in the Collaborative Cross
$859,591Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI
COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2
$859,275Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$857,976John Hsu · Massachusetts General Hospital · U01 · FY2021 · AG
mRNA Nuclear Export Machinery as Target of SARS-CoV-2 Nsp1 Protein
$857,199Yi Ren · Vanderbilt University · R01 · FY2024 · AI
The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies
$856,430James J Kobie · University Of Alabama At Birmingham · R01 · FY2021 · AI
Pulmonary pathophysiology sub-phenotypes of pneumonia
$856,279Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2022 · AI
Methods to accelerate protein structure determination by solution NMR
$855,890Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Quantitative high-throughput methods for antibody fragment optimization and discovery
$855,260Curtis Layton · Protillion Biosciences, Inc. · R44 · FY2022 · GM
Quantitative high-throughput methods for antibody fragment optimization and discovery
$855,260Curtis Layton · Protillion Biosciences, Inc. · R44 · FY2021 · GM
Molecular mechanisms of aging and accelerated aging in the human brain
$855,196Maria Mavrikaki · Beth Israel Deaconess Medical Center · R01 · FY2024 · AG
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
$855,062Sabra L Klein · Johns Hopkins University · U54 · FY2020 · CA
Early life B cell responses and inflammation following SARS-CoV-2 infection
$854,272Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2021 · AI
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$853,827Steven B Abramson · New York University School Of Medicine · R01 · FY2023 · HL
CORALE-SeroNet Immune Bioanalytics Core
$853,280Jennifer E Van Eyk · Cedars-Sinai Medical Center · U54 · FY2020 · CA
Early life B cell responses and inflammation following SARS-CoV-2 infection
$852,895Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Neural, Physiological, Behavioral, and Environmental Risk Markers of Anxiety from Infancy to Adolescence
$852,830Michelle A Bosquet Enlow · Boston Children'S Hospital · R01 · FY2023 · MH
Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2
$852,747Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Study of Pregnancy And Neonatal Health (SPAN)
$852,148Edwina Yeung · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
COVID-19 vaccine in naive individuals and cancer patients
$851,991Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Structure and Function of Vif and APOBEC3 (A3) Proteins
$850,901Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health Equity - (WHA REACH Equity Study)
$850,588Joan Packenham · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology
$850,444Raymond Goodrich · Colorado State University · N01 · FY2024 · AI